Related Experiment Video

Updated: Aug 15, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media

S L Block1

  • 1Kentucky Pediatric Research, Bardstown 40004, USA.

The Pediatric Infectious Disease Journal
|April 1, 1997
PubMed

Insights

Newer macrolides like azithromycin and clarithromycin are effective alternatives for acute otitis media (AOM). They show better activity against resistant bacteria and achieve higher middle ear fluid concentrations than traditional antibiotics.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pediatrics

Background:

  • Acute otitis media (AOM) is commonly caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
  • Increasing antibiotic resistance, including penicillin-resistant S. pneumoniae and beta-lactamase-producing H. influenzae and M. catarrhalis, challenges traditional amoxicillin therapy for AOM.
  • Selecting appropriate antibiotics for refractory AOM requires considering both in vitro activity and middle ear fluid concentrations.

Purpose of the Study:

  • To evaluate the efficacy of newer macrolides against common AOM pathogens, considering emerging antibiotic resistance.
  • To compare the middle ear fluid concentrations of macrolides versus beta-lactam antibiotics.

Main Methods:

  • In vitro antibiotic activity testing against key AOM pathogens.
  • Pharmacokinetic analysis of antibiotic concentrations in middle ear fluid.

Main Results:

  • Newer macrolides (azithromycin, clarithromycin) demonstrate reasonable in vitro coverage against penicillin-resistant S. pneumoniae and beta-lactamase-producing H. influenzae.
  • Azithromycin exhibits greater activity against beta-lactamase-producing H. influenzae compared to clarithromycin.
  • Macrolides achieve higher and more sustained middle ear fluid concentrations than beta-lactam antibiotics.

Conclusions:

  • Newer macrolides offer a rational alternative for managing AOM, particularly in cases involving resistant pathogens.
  • The favorable pharmacokinetic profile of macrolides in middle ear fluid supports their use in AOM treatment.
  • Azithromycin and clarithromycin represent valuable options for treating acute otitis media, addressing challenges posed by antibiotic resistance.

More Related Videos

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...